16th January 2011
After a sabbatical from private practice we are delighted that Andrew Doble has rejoined the practice. Andrew is a recognised leader in the field of prostate cancer and protatitis, and has a wealth of experience in the field of urology. He has further interests in minimally invasive treatments such as cryotherapy for kidney cancer. Andrew has recently been elected to the renal cancer Clinical Studies Group at the NCRI and is also a committee member of the British Prostate Group (BPG). He has been a consultant at Addenbrooke’s Hospital since 1993. To read more about him, please click here.